RACHEL SNYDER: Open Payments
NPI 1235604661 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 26 payments from 9 companies in 2025. Trend: 2023 $729 · 2024 $838 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $147 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Novo Nordisk Inc | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Philips North America LLC | 2 | $30 |
| Boston Scientific Corporation | 1 | $28 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: ELIQUIS, LEQVIO, JARDIANCE, VYNDAQEL, BodyGuardian, CAMZYOS, Wegovy, Attruby.
Industry payments across KY — which companies pay providers there.
